Innovative cancer drug targets: Genomics, transcriptomics and clinomics

Expert Opinion on Pharmacotherapy

Volumn 2, Issue 6, 2001, Pages 911-915

  Workman, P ^a   Clarke, P A ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; CHAPERONE; GEFITINIB; HEAT SHOCK PROTEIN 90; IMATINIB; MESSENGER RNA; PROTEIN INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TRASTUZUMAB;

CANCER; CANCER GENETICS; COMBINATORIAL CHEMISTRY; DRUG DESIGN; DRUG MECHANISM; DRUG TARGETING; EDITORIAL; ENVIRONMENTAL FACTOR; FUSION GENE; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; HUMAN; ONCOGENE; ONCOGENE NEU; TECHNOLOGY;

DRUG DELIVERY SYSTEMS; DRUG DESIGN; FORECASTING; GENOME, HUMAN; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 0034863637     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2.6.911     Document Type: Editorial

References (40)

1. Essential drugs for cancer therapy: A World Health Organisation consultation
2. The hallmarks of cancer
3. Millennium review. Discovering novel chemotherapeutic drugs for the third millennium
4. Mechanism-based target identification and drug discovery in cancer research
5. Genomic sciences and the medicine of tomorrow
6. Drug discovery: A historical perspective
7. Innovation in the pharmaceutical industry
8. Has R&D failed the pharmaceutical industry?
9. Use of chemotherapy plus a monoclonal antibody against HER2 for metastic breast cancer that overexpresses HER2
10. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
11. ZD1839 ('Iressa') as an anticancer agent
12. International human genome sequencing consortium: Initial sequencing and analysis of the human genome
13. The sequence of the human genome
14. The human genome, in proportion
15. A cold dose of medicine
16. Our genome unveiled
17. What if there are only 30,000 human genes?
18. Human disease genes
19. Dissecting human disease genes in the post genomic era
20. The sequence: Inside the race for the human genome
21. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
22. Gazing into a crystal ball - Cancer therapy in the post-genome era
23. Genomics, gene expression and DNA arrays
24. Can sequencing shed light on cell cycling?
25. Cancer and genomics
26. Oncogenes and the molecular origins of cancer
27. The multistep nature of cancer
28. Creation of human tumour cells with defined genetic elements
29. Molecular portraits of human breast tumours
30. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
31. DNA microarrays in drug discovery and development
32. Gene expression profiling in drug discovery
33. Gene expression microarray analysis in cancer biology, pharmacology and drug development: Progress and potential
34. A gene expression database for the molecular pharmacology of cancer
35. Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxy geldanamycin, an inhibition of the Hsp90 molecular chaperone
36. All hands on deck at dawn
37. Dt-diaphorase expression and tumour cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90
38. Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino - 17 demethoxy geldanamylin results in cytostasis and apoptosis
39. Vapornomics